NatWest Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-506,351
Closed -$8.31M 161
2015
Q3
$8.31M Sell
506,351
-10,627
-2% -$182K 0.19% 72
2015
Q2
$9.15M Sell
516,978
-1,935
-0.4% -$34.6K 0.12% 69
2015
Q1
$9.21M Buy
518,913
+311,231
+150% +$4.92M 0.12% 75
2014
Q4
$2.75M Buy
+207,682
New +$2.65M 0.02% 151
2014
Q1
Sell
-107,948
Closed -$1.3M 569
2013
Q4
$1.3M Buy
107,948
+21,211
+24% +$251K 0.03% 365
2013
Q3
$1.02M Sell
86,737
-171,695
-66% -$1.86M 0.03% 426
2013
Q2
$2.4M Buy
+258,432
New +$2.19M 0.03% 285

Other funds holding BSX

NatWest Group's BSX Position: Q4 2015 in Review

NatWest Group sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 506,351 shares — an estimated $8.31M sold.

NatWest Group first reported a position in BSX in Q2 2013 and held it in 7 quarters. The position peaked at $9.21M in Q1 2015. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

  • NatWest Group reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 506,351 Boston Scientific shares in Q4 2015, an estimated $8.31M.
  • NatWest Group first reported a position in Boston Scientific in Q2 2013 and held it in 7 quarters.
  • NatWest Group's Boston Scientific position peaked at $9.21M in Q1 2015.
  • 502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.